.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The PARTNER trial tested a multicomponent family-support intervention in ICUs caring for patients at high risk of death. Rather than focusing on a single communication tool, the intervention embedded structured support for surrogates within the interprofessional ICU team's routine practice. The study addressed an important but often under-measured problem: families can experience major psychological distress while trying to understand prognosis, treatment choices and uncertainty. High-quality communication is particularly important when decisions about life support and goals of care are being made. The trial found that a structured family-support approach improved aspects of communication and patient- and family-centred care, highlighting the value of making communication a reproducible clinical process rather than relying on individual clinician style. This fits CritiCARE 2026's explicit focus on humanisation, family presence, end-of-life decision-making, communication and dignity. For HCPs, the practical implication is that family support should include preparation, consistent information, opportunities for questions, acknowledgement of uncertainty and clear documentation of decisions. The study also reinforces that family-centred care is not separate from clinical quality; it is part of it. The intervention offers a useful model for ICU teams seeking to standardise communication while preserving compassion and individualisation.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The PARTNER trial tested a multicomponent family-support intervention in ICUs caring for patients at high risk of death. Rather than focusing on a single communication tool, the intervention embedded structured support for surrogates within the interprofessional ICU team's routine practice. The study addressed an important but often under-measured problem: families can experience major psychological distress while trying to understand prognosis, treatment choices and uncertainty. High-quality communication is particularly important when decisions about life support and goals of care are being made. The trial found that a structured family-support approach improved aspects of communication and patient- and family-centred care, highlighting the value of making communication a reproducible clinical process rather than relying on individual clinician style. This fits CritiCARE 2026's explicit focus on humanisation, family presence, end-of-life decision-making, communication and dignity. For HCPs, the practical implication is that family support should include preparation, consistent information, opportunities for questions, acknowledgement of uncertainty and clear documentation of decisions. The study also reinforces that family-centred care is not separate from clinical quality; it is part of it. The intervention offers a useful model for ICU teams seeking to standardise communication while preserving compassion and individualisation.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
